Also, by using alternative GRSs to measure the combined effect of NAFLD risk alleles, we excluded any involvement of TM6SF2, GCKR, and MBOAT7 gene variants. The gene discussed is MBOAT7; the disease is metabolic dysfunction-associated steatotic liver disease.